Keyphrases
Cardiovascular Magnetic Resonance Imaging
100%
Cardiomyopathy
76%
Patients with Coronary Artery Disease
76%
Nonischemic Cardiomyopathy
76%
Non-ischemic
76%
Cardiac Sarcoidosis
76%
Late Gadolinium Enhancement
76%
Imaging Phenotypes
76%
Coronary Artery Disease
53%
Left Ventricular Ejection Fraction
33%
Hazard Ratio
32%
Heart Failure Hospitalization
23%
All-cause Mortality
23%
Obstructive Coronary Artery Disease
23%
High Risk
22%
Cardiovascular Mortality
15%
Coronary Revascularization
15%
Prognostic Benefit
15%
Sarcoidosis
14%
Heart Failure Events
14%
Consecutive Patients
12%
Feature Enhancement
9%
Left Ventricular Function
9%
Hispanic or Latino
9%
Adverse Outcomes
9%
Coronary Angiography
7%
Multivariable
7%
Registry Study
7%
Ventricular Scar
7%
Magnetic Resonance Coronary Angiography
7%
Potential Confounders
7%
Prognostic Significance
7%
Ischemic Cardiomyopathy
7%
Contrast Enhancement
7%
Randomized Trial
7%
Ventricular Function
7%
Magnetic Resonance Angiography
7%
Clinical Outcomes
7%
Adjusted Hazard Ratio
7%
Medicine and Dentistry
Cardiac Magnetic Resonance Imaging
94%
Cardiac Sarcoidosis
76%
Coronary Artery Disease
76%
Gadolinium
76%
Myocardial Disease
76%
Nonischemic Cardiomyopathy
59%
Heart Left Ventricle Ejection Fraction
33%
Hazard Ratio
33%
Congestive Heart Failure
32%
Cause of Death
17%
Sarcoidosis
14%
Heart Muscle Revascularization
11%
Coronary Angiography
11%
Cardiovascular System
11%
Cohort Analysis
9%
Adverse Outcome
9%
Prevalence
5%
Ischemic Cardiomyopathy
5%
Heart Ventricle Function
5%
Pharmacology, Toxicology and Pharmaceutical Science
Gadolinium
76%
Coronary Artery Disease
76%
Cardiac Sarcoidosis
76%
Myocardial Disease
76%
Nonischemic Cardiomyopathy
59%
Congestive Heart Failure
32%
Cause of Death
17%
Sarcoidosis
14%
Cohort Study
9%
Adverse Outcome
9%
Prevalence
5%
Ischemic Cardiomyopathy
5%